Desq Long
Sign in

Company

Decoy Therapeutics Inc.

DCOY · CIK 0001615219

SEC FORM 4
$0.00

Decoy Therapeutics Inc. (DCOY)

Acquisition (code A) of 2,000 shares at $0 per share.

Reporting Person Lieber Jonathan I · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-380584 · filed 2026-09-02 · View filing →

SEC FORM 4
$0.00

Decoy Therapeutics Inc. (DCOY)

Acquisition (code A) of 33,455 shares at $0 per share.

Reporting Person PIERCE FREDERICK II · Officer Title Chief Executive Officer · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001229055-26-000002 · filed 2026-09-02 · View filing →

SEC FORM 4
$0.00

Decoy Therapeutics Inc. (DCOY)

Acquisition (code A) of 3,000 shares at $0 per share.

Reporting Person HANISH ARNOLD C · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001233253-26-000006 · filed 2026-09-02 · View filing →

SEC FORM 4
$0.00

Decoy Therapeutics Inc. (DCOY)

Acquisition (code A) of 9,682 shares at $0 per share.

Reporting Person Rosenblum Mark J · Officer Title Chief Financial Officer · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001329154-26-000003 · filed 2026-09-02 · View filing →

SEC FORM 4
$0.00

Decoy Therapeutics Inc. (DCOY)

Acquisition (code A) of 2,000 shares at $0 per share.

Reporting Person Lammers Paul · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001457289-26-000003 · filed 2026-09-02 · View filing →

SEC FORM 4
$0.00

Decoy Therapeutics Inc. (DCOY)

Acquisition (code A) of 3,000 shares at $0 per share.

Reporting Person McVicar William K. · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001634368-26-000003 · filed 2026-09-02 · View filing →

SEC FORM 4
$0.00

Decoy Therapeutics Inc. (DCOY)

Acquisition (code A) of 2,000 shares at $0 per share.

Reporting Person Burleson Tess · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001769749-26-000003 · filed 2026-09-02 · View filing →

SEC FORM 4
$0.00

Decoy Therapeutics Inc. (DCOY)

Acquisition (code A) of 4,216 shares at $0 per share.

Reporting Person Hibner Barbara Louise · Officer Title Chief Scientific Officer · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0002079512-26-000002 · filed 2026-09-02 · View filing →

SEC FORM 4
$0.00

Decoy Therapeutics Inc. (DCOY)

Acquisition (code A) of 3,900 shares at $0 per share.

Reporting Person Marschel Peter Klaus · Officer Title Chief Business Officer · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0002079859-26-000002 · filed 2026-09-02 · View filing →

SEC FORM 4
$0.00

Decoy Therapeutics Inc. (DCOY)

Acquisition (code A) of 2,000 shares at $0 per share.

Reporting Person Gauthier Patricia G. · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0002148287-26-000002 · filed 2026-09-02 · View filing →